Berg, Glickman join Oscient

Oscient Pharmaceuticals Corp. of Waltham said today it has named two executives with extensive cardiovascular experience to its management team.

The company said it has named Aaron D. Berg as vice president of marketing and Michael A. Glickman as vice president of sales, effective immediately.

Oscient said both men were previously part of the commercial team at Kos Pharmaceuticals.

Oscient markets such drugs as Antara, for high blood pressure, and Factive, an antibiotic for the treatment of acute bacterial exacerbations of chronic bronchitis.
(By Chris Reidy, Globe staff)